Three trials ( n = 13168) explored the benefit of DAPT 3Mo + P2Y12 and all bleeding events were reduced with a favorable trend to lower ischemic harm [ 5 , 7 , 8 ].
← all excerpts
Efficacy and Safety of Dual Antiplatelet Therapy in Patients Undergoing Coronary Stent Implantation: A Systematic Review and Network Meta-Analysis.
1
—
—